Brief: Kura Oncology Reports Preclinical Data

Kura Oncology

24/06/2024 12:32

June 24 (Reuters) - Kura Oncology Inc  KURA.O :
    * KURA ONCOLOGY REPORTS PRECLINICAL DATA SUPPORTING
POTENTIAL FOR
MENIN INHIBITOR IN DIABETES
    * KURA ONCOLOGY INC: ZIFTOMENIB INDUCES INSULIN PRODUCTION
    * KURA ONCOLOGY INC: ZIFTOMENIB IMPROVES INSULIN SENSITIVITY
    * KURA ONCOLOGY INC: ZIFTOMENIB REDUCES INSULIN RESISTANCE

Source text for Eikon:  ID:nGNX25F8Tj 
Further company coverage:  KURA.O 

 ((Reuters.Briefs@thomsonreuters.com;))